Diagonal Bio AB Second Quarter Report (Q2 2024)
English, Interim, IR, MAR, News, Q2, Regulatory, Report“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections and the interest in our Point-of-Care instrument continue to deepen.”Summary…
Diagonal Bio receives order from the Technical University of Denmark
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has secured an order from the Technical University of Denmark (“DTU”) valued at just over 210,000 SEK for fish farms’ health project HURTIGFISK.…
Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB
English, IR, News, RegulatoryToday, on 11 June 2024, the Annual General Meeting of Diagonal Bio AB was held. A summary of the adopted resolutions follows below.Resolution on adoption of the accounts and appropriation of profitThe Annual General Meeting resolved to adopt…
Diagonal Bio AB first quarter (Q1 2024)
English, Interim, IR, News, Q1, Regulatory, Report“The end of last year was marked by our focus on creating the business platform to generate the company's initial revenue in 2024. We continue and gear up on the set path with a focus on generating revenue”.Summary of Q1 report 20242024-01-01…
Diagonal Bio appoints new CFO
English, IR, News, RegulatoryDiagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has appointed Fata Mrsic as the new Chief Financial Officer (CFO). Fata will assume the position on June 14, 2024, and be part of the Management Team.Fata Mrsic…
Diagonal Bio announces strategic pilot study with Löberöds Hästklinik
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) is pleased to announce a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement,…
Diagonal Bio AB Annual Report 2023
Annual, English, IR, News, Regulatory, ReportThe Board of Directors and CEO of Diagonal Bio AB hereby publish the Annual Report for the fiscal year 2023.
The Annual Report is available as an attached file to this release and on Diagonal Bio’s website (www.diagonalbio.com/investors/financial-reports).Documents
Diagonal…
Kallelse till årsstämma i Diagonal Bio AB
English, IR, News, RegulatoryAktieägarna i Diagonal Bio AB (publ), org.nr 559248-8984, (”Bolaget”) kallas härmed till årsstämma tisdagen den 11 juni 2024 kl. 13.00. Stämman hålls på Medicon Village, Scheeletorget 1 i Lund.Rätt…
Diagonal Bio AB announces last day of trading in BTU and first day of trading in TO 1
English, IR, News, RegulatoryDiagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units, with a subscription period ending on April 22, 2024, has now been registered at the Swedish Companies Registration Office. The Company hereby announces that the last…
Diagonal Bio AB announces outcome of rights issue
English, IR, MAR, News, RegulatoryNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…
